Humana financials
$386.87−0.71%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $128.59B | $116.53B | $105.31B | $92.49B | $82.88B | $76.00B | $64.39B | $56.40B | $53.36B | $53.99B |
| Gross profit | $17.78B | $15.87B | $16.91B | $16.80B | $13.68B | $14.37B | $10.53B | $10.52B | $9.87B | $8.98B |
| Gross margin | 13.8% | 13.6% | 16.1% | 18.2% | 16.5% | 18.9% | 16.4% | 18.6% | 18.5% | 16.6% |
| Operating income | $1.63B | $1.34B | $2.94B | $3.42B | $2.96B | $3.83B | $2.69B | $2.59B | $3.86B | $1.35B |
| Net income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614.0M |
| Net margin | 0.9% | 1.0% | 2.4% | 3.0% | 3.5% | 4.4% | 4.2% | 3.0% | 4.6% | 1.1% |
| Diluted EPS | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 |
| EBITDA | $2.46B | $2.30B | $3.86B | $4.26B | $3.67B | $4.45B | $3.27B | $3.12B | $3.41B | $1.92B |
| Operating cash flow | $921.0M | $2.97B | $3.98B | $4.59B | $2.26B | $5.64B | $5.28B | $2.17B | $4.05B | $1.94B |
| Free cash flow | $375.0M | $2.39B | $2.98B | $3.45B | $920.0M | $4.67B | $4.55B | $1.56B | $3.53B | $1.41B |
| Diluted shares | 120.8M | 120.9M | 124.4M | 127.1M | 129.4M | 133.0M | 134.7M | 138.4M | 145.6M | 150.9M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $12.37B | $11.72B | $11.66B | $11.13B | $12.49B | $6.66B |
| Total assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B |
| Total liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B | $21.24B |
| Shareholders' equity | $17.74B | $16.45B | $16.32B | $15.37B | $16.10B | $13.73B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology